Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Post-ESWL urinary osteopontin level and ion-activity product of calcium oxalate are associated with stone recurrence after 5-year follow-up

Fig. 2

Changes in urinary expression of anticrystallization molecules. (a) Stone patients exhibited a significant increase in urinary OPN (Osteopontin, 44 kDa) levels at 2-week and 4-week post-ESWL in comparison to pre-ESWL levels and controls (b) Urinary THP(Tamm-Horsfall protein, 95 kDa) levels remained consistent across samples collected before ESWL and at 2-week and 4-week intervals post-ESWL in stone patients

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us